Nucleate Global Virtual Activator: 2025 Demo Day

​17 teams, 55 entrepreneurs, 25 countries, 41 cities.

​These bio-entrepreneurs have converged at Nucleate's Global Virtual Activator (GVA). Working with 125+ experts in tailored workshops and 20+ mentors to refine their venture strategies, our venture teams have undergone tremendous growth over the past few months—and are eager to showcase it at Demo Day. Teams will pitch to an esteemed panel of judges: all bio-enthusiasts welcome!

​​The Global Virtual Activator expands Nucleate's flagship program to life sciences entrepreneurs in regions that don't yet have a robust Nucleate presence—advancing our mission to democratize access to biotech entrepreneurship education for tomorrow’s industry leaders at a global scale.

​We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!

​Platinum: Eli Lilly and Company, Genentech, Alnylam Pharmaceuticals, MilliporeSigma 

​Philanthropic Support: Lyda Hill Philanthropies

​Preferred Partners: Pillar VC, Amino Collective, Excedr, Mercury, Brex, Fedsprout

​In-Kind Support: AcademicLabs, Lens.org, SynBioBeta

​About the Event Host

​​​Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.xyz for more information, and visit https://nucleate.xyz/privacy-policy/ to read our privacy policy.